Practical considerations in clinical strategy to support the development of injectable drug-device combination products for biologics
Sign Up to like & getrecommendations! Published in 2018 at "mAbs"
DOI: 10.1080/19420862.2017.1392424
Abstract: ABSTRACT The development of an injectable drug-device combination (DDC) product for biologics is an intricate and evolving process that requires substantial investments of time and money. Consequently, the commercial dosage form(s) or presentation(s) are often… read more here.
Keywords: injectable drug; drug device; strategy; development ... See more keywords